Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serotonin neurons are specialized nerve cells that synthesize, store, and release serotonin (5-hydroxytryptamine, 5-HT), a key neurotransmitter involved in regulating mood, emotion, sleep, appetite, aggression, cognition, and many other physiological processes. These neurons primarily originate from the raphe nuclei in the brainstem and project widely throughout the central nervous system. Alterations in serotonergic neuron function are implicated in psychiatric disorders such as depression and anxiety as well as neurological conditions affecting pain perception. Many antidepressants act by increasing serotonin availability at synapses by inhibiting its reuptake.
SSRIs: Inhibit serotonin reuptake. SNRIs: Inhibit serotonin and norepinephrine reuptake. TCAs: Inhibit reuptake of serotonin and norepinephrine. MAOIs: Inhibit the breakdown of serotonin, norepinephrine, and dopamine.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Neuron.